Verastem verastem.com


Public list: BIO 2016 (619) Smart Money VCs (6326) Pharma Startups (6570) Cancer Therapeutics (1180)

Verastem is a biopharmaceutical company focused on discovering and developing drugs that selectively target cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer.

Verastem is a biopharmaceutical company focused on discovering and developing drugs that selectively target cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is translating breakthrough discover...Show all

Company (IPO / Went public)

Phone:

Fax:

215 First Street
Suite 440
Cambridge, 02142
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Verastem $68.1M Jan 30, 2012

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Verastem Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Therapeutic compositions, combinations, and methods of use Jun 29, 2016 Jan 14, 2020 Patent
Methods and compositions for treating abnormal cell growth Apr 02, 2018 Sep 10, 2019 Patent
Methods and compositions for treating abnormal cell growth Feb 06, 2015 May 08, 2018 Patent
Synthesis and use of kinase inhibitors Aug 07, 2013 Nov 29, 2016 Patent
Oral formulations of kinase inhibitors Aug 14, 2013 Jun 28, 2016 Patent
See all 16 patents